FGF-4 Gene Therapy GENERX - Collateral Therapeutics: Ad5FGF4, Fibroblast Growth Factor-4 Gene Therapy GENERX - Collateral Therapeutics, GENERX

Author：  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.16, Iss.1, 2002-01, pp. : 75-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13

By Zavorotinskaya T.   Tomkinson A.   Murphy J.E.  

Molecular Therapy, Vol. 7, Iss. 2, 2003-02 ,pp. : 155-162

Elsevier

Access to resources Recommend Favorite

Systemic Delivery of a High-Capacity Adenoviral Vector Expressing Mouse CTLA4Ig Improves Skeletal Muscle Gene Therapy

By Jiang Z.   Feingold E.   Kochanek S.   Clemens P.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 369-376

Elsevier

Access to resources Recommend Favorite

INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy – Introgen, RPR/INGN 201

By  

BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 216-222

Adis International

Access to resources Recommend Favorite

CD4 cell response to interval therapy with natalizumab

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 5, 2015-05 ,pp. : 570-574

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gene therapy for asthma

By Factor P.  

Molecular Therapy, Vol. 7, Iss. 2, 2003-02 ,pp. : 148-152

Elsevier

Access to resources Recommend Favorite